从甲基形态动力学对KRAS的效应器和叶之间的交叉对话的洞察
Fa-An Chao1, Srisathiyanarayanan Dharmaiah1, Troy Taylor1
1NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, Maryland 21701, United States.
Journal of the American Chemical Society
|February 25, 2022
概括
研究人员使用NMR研究了KRAS蛋白的动态,以了解癌症突变. 定制的NMR技术揭示了同步的运动影响下游效应器如RAF1,有助于预测突变的结合亲和力.
科学领域:
- 生物物理
- 分子生物学
- 癌症研究
背景情况:
- KRAS是癌症中最常发生突变的RAS蛋白,影响美国约20%的癌症患者.
- RAS蛋白结构和动态对于治疗发展至关重要,但复杂的结构动态仍然具有挑战性.
- 之前的研究,包括31P NMR,确定了主要状态,但错过了影响效应因子相互作用的微妙动态.
研究的目的:
- 系统地检查RAS蛋白的毫秒到微秒的结构动态.
- 研究这些动态如何调节与下游效应器的相互作用,特别是KRAS和RAF1.
- 基于KRAS突变的改变结合亲和力的预测框架的开发.
主要方法:
- 建立了定制的核磁共振放松分散技术.
- 应用这些技术有效地和系统地探测ms-micro形态动力学.
- 研究了KRAS和RAF1的Ras结合域之间的相互作用.
主要成果:
- 在KRAS中观察到不同的同步运动连接了效应器和异质叶.
- 证明了KRAS结构动态在控制其与RAF1相互作用中的关键作用.
- 为解释和预测KRAS突变的改变结合亲缘关系提供了动态基础.
结论:
- 定制的NMR放松分散对于研究KRAS形态动态是有效的.
- 构造动态是KRAS效应器相互作用和突变结合亲缘关系的关键决定因素.
- 这项工作为KRAS介导的信号和潜在的治疗策略提供了新的见解.
相关概念视频
Cooperative Allosteric Transitions
2.6K
2.6K
Allosteric Regulation
60.2K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
60.2K
Ligand Binding and Linkage
5.0K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.0K
MAPK Signaling Cascades
6.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.4K
Allosteric Proteins-ATCase
6.0K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.0K
Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K


